Based on the earnings conference call transcripts, the financial analyst report summary is as follows:
- Sales for the quarter were $29.4 billion, down 2.4% versus the comparable quarter, but up 0.9% on a constant currency basis.
- GAAP operating income was $1.5 billion, a decrease of 20.5%.
- GAAP net earnings attributable to Walgreens Boots Alliance were $1.1 billion, up 14%, and diluted EPS was $0.98, up 15.3%.
- Adjusted operating income was $2 billion, down 4.9% and constant currency was down 2.7%. Adjusted net earnings attributable to Walgreens Boots Alliance were $1.5 billion, up 3.7% and in constant currency up 6.2%. Adjusted diluted net earnings per share was $1.36, up 3.8% and in constant currency up 6.1%.
- U.S. Pharmacy total sales were up 3.7% mainly driven by increased retail script volume. Claims in the consumables and general merchandise and personal care categories partially offset by solid growth in health and wellness and beauty categories.
- Cost transformation program achieved a target of $1.5 billion in savings ahead of plan, with expected cumulative pretax charges of approximately $1.8 billion.
- Retail Pharmacy international division saw a decrease in comparable pharmacy sales due to a reduction in government pharmacy funding.
- Pharmaceutical wholesale division saw  sales of $5 billion, up 0.6% versus the same quarter last year on a constant currency basis.
- Operating cash flow in the quarter was $2.9 billion, with a working capital inflow of $1.4 billion and free cash flow of $2.6 billion. 
- New share repurchase program of up to $1 billion announced, with flexibility due to the changes to the pending Rite Aid transaction.

Overall, the company's financial performance has shown mixed results, with some positive growth in U.S. Pharmacy sales but challenges in international divisions and impact from currency fluctuations. The cost transformation program has achieved its target, and the company continues to focus on driving efficiency and maximizing opportunities. The announcement of a new share repurchase program also demonstrates the company's commitment to maximizing shareholder value.